OncoLink en espanõl
Share
Types of Cancer > Lung Cancers > Non-Small Cell Lung Cancer > News
August 2009
Erlotinib improves survival in stage III non-small cell lung cancer
July 2009
PET-CT improves preoperative staging of non-small cell lung cancer
November 2008
VDR polymorphisms linked with survival in advanced NSCLC
October 2008
Video-assisted lobectomy shortens hospital length of stay
NSCLC in never-smokers a separate disease from NSCLC in smokers
Third-generation chemotherapy for advanced NSCLC linked to better survival
August 2008
Cisplatin-based chemo improves post-op survival in NSCLC
March 2008
Nimotuzumab boosts effect of ionizing radiation against some NSCLCs
Enzastaurin shows promise as second- or third-line therapy in NSCLC
Combination chemotherapy better than erlotinib as initial treatment for advanced NSCLC
Biomarker profile may allow tailored treatment of non-small cell lung cancer
January 2008
Three-gene panel predicts survival in non-small cell lung cancer
October 2007
PET signal after lung biopsy or wedge resection may lead to misdiagnosis
July 2007
Stage 1 non-small cell lung cancer benefits from early aggressive treatment
June 2007
Shark cartilage extract of no benefit in non-small cell lung cancer
April 2007
Thoracoscopic lobectomy improves chemotherapy delivery for lung cancer
March 2007
Erlotinib improves NSCLC survival without major toxicity in the elderly
February 2007
Incidentally detected lung cancers less likely to require pneumonectomy
January 2007
Lobectomy may be better than wedge resection for stage IA lung cancers
July 2006
Benefits of surgery for non-small cell lung cancer unclear
October 2005
Gefitinib does not improve survival in refractory advanced NSCLC
May 2005
Hispanics fare worse than whites after stage I non-small cell lung cancer diagnosis
April 2005
Trial of Iressa for advanced NSLCC halted for lack of efficacy
October 2004
Video-guided lobectomy effective as open surgery against lung cancer
September 2004
Smaller stage I non-small cell lung cancers more curable than larger tumors
June 2004
Postop combination chemo prolongs survival in early NSCLC
November 2003
Findings argue for substaging for tumour size within stage IA NSCLC
August 2003
PET imaging predicts response to chemotherapy for non-small cell lung cancer
July 2003
First-line docetaxel improves survival in advanced non-small cell lung cancer
June 2003
Radical en bloc resection advised for NSCLC with chest wall invasion
Erlotinib active against hard-to-treat NSCLC subtype
May 2003
R115777 shows minimal activity against advanced non-small cell lung cancer
FDA approves AstraZeneca's Iressa for non-small cell lung cancer
December 2001
Gene expression patterns distinguish subtypes of non-small cell lung cancer
November 2001
Limited resection often preferable to lobectomy for elderly lung cancer patients
August 2001
Video-assisted pulmonary lobectomy shows benefits over standard approach
Pleural lymphocytes may aid prognosis in non-small cell lung cancer
April 2001
Fluorescence bronchoscopy detects non-small cell lung cancer recurrence
March 2001
PET scan staging predicts survival in patients with non-small cell lung cancer
July 2000
Cell Pathways, Glaxo Wellcome to conduct non-small cell lung cancer study
March 1999
Non-small cell lung cancer lesions missed on chest radiograph in 19% of cases